Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Pemigatinib Tablets

Approval Number

国药准字HJ20220028

CompanyIncyte Biosciences Distribution B.V.

Registration Date

March 29, 2022

Drug Information

Generic Name

佩米替尼片

Trade Name

达伯坦

Dosage Form

片剂

Strength

9mg

Drug Type

化学药品

Registration Date

March 29, 2022

Expiry Date

March 28, 2027

Company Information

Applicant Company

Company NameIncyte Biosciences Distribution B.V.

Company Address

Paasheuvelweg 25, 1105 BP Amsterdam, Netherlands

Manufacturing Company

Company NameLonza Tampa Llc

Company Address

4910 Savarese Circle, Tampa, Florida, 33634, USA

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy